SCHEMBL5834764

SCHEMBL5834764

CCN(CC)c1ccc(NC(=O)[C@]2(N(CC(C)C)C(=O)O)CCc3cc(C=CC(N)=O)ccc3C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.41
KCNH2 Q12809 1/20 0.41
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
MAPT P10636 4/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
CNR2 P34972 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
FGFR1 P11362 1/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
NOX1 Q9Y5S8 1/20 0.32
GAA P10253 3/20 0.32
POLB P06746 3/20 0.32
GFER P55789 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835333 1.00 GHSR (0.41) GHSRKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5835330 1.00 GHSR (0.41) GHSRKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5834760 1.00 GHSR (0.41) GHSRKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5835479 0.84 GHSR (0.45) GHSRKCNH2ALDH1A1MAPTLMNA
SCHEMBL5835384 0.84 GHSR (0.45) GHSRKCNH2ALDH1A1MAPTLMNA
SCHEMBL5835248 0.83 GHSR (0.49) GHSRKCNH2ALDH1A1MAPTLMNA
SCHEMBL5835661 0.83 GHSR (0.49) GHSRKCNH2ALDH1A1MAPTLMNA
SCHEMBL5834757 0.78 GHSR (0.71) GHSRKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5835325 0.78 GHSR (0.71) GHSRKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5836507 0.75 GHSR (0.61) GHSRKCNH2MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885ALDH1A1 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.